Michael L. Levitz

Chief Financial Officer, Analogic Corporation.

Companies

Anika Therapeutics, Inc.Chief financial officer Aug 12, 2020 to Mar 19, 2024¹
Insulet (United States)Chief financial officer May 4, 2015 to Feb 28, 2019²
Analogic CorporationChief financial officer Jul 8, 2009 to Apr 3, 2015³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 11, 2024Shares withheld for tax 2,610 shares at $25.79 of Anika Therapeutics, Inc.⁴
Mar 11, 2024Exercised options 8,888 shares of Anika Therapeutics, Inc.⁴
Mar 11, 2024Shares withheld for tax 1,725 shares at $25.42 of Anika Therapeutics, Inc.⁴
Mar 11, 2024Exercised options 5,875 shares of Anika Therapeutics, Inc.⁴
Mar 11, 2024Shares withheld for tax 1,303 shares at $25.42 of Anika Therapeutics, Inc.⁴
Mar 11, 2024Exercised options 4,438 shares of Anika Therapeutics, Inc.⁴
Aug 10, 2023Shares withheld for tax 1,133 shares at $18.58 of Anika Therapeutics, Inc.⁵
Aug 10, 2023Exercised options 3,859 shares of Anika Therapeutics, Inc.⁵
Mar 10, 2023Shares withheld for tax 2,609 shares at $26.10 of Anika Therapeutics, Inc.⁶
Mar 10, 2023Exercised options 8,888 shares of Anika Therapeutics, Inc.⁶
Mar 9, 2023Shares withheld for tax 1,303 shares at $26.91 of Anika Therapeutics, Inc.⁷
Mar 9, 2023Exercised options 4,439 shares of Anika Therapeutics, Inc.⁷
Aug 10, 2022Exercised options 3,859 shares of Anika Therapeutics, Inc.⁸
Mar 11, 2022Bought 4,000 shares at $24.62 of Anika Therapeutics, Inc.⁹
Mar 9, 2022Exercised options 4,438 shares of Anika Therapeutics, Inc.¹⁰

The numbers on this page point here. Each one links to the record it came from.